| Updates on the web-based VIOLIN vaccine database and analysis system Y He, R Racz, S Sayers, Y Lin, T Todd, J Hur, X Li, M Patel, B Zhao, ... Nucleic acids research 42 (D1), D1124-D1132, 2014 | 77 | 2014 |
| Association between serotonin syndrome and second‐generation antipsychotics via pharmacological target‐adverse event analysis R Racz, TG Soldatos, D Jackson, K Burkhart Clinical and translational science 11 (3), 322-329, 2018 | 55 | 2018 |
| Evaluating kratom alkaloids using PHASE CR Ellis, R Racz, NL Kruhlak, MT Kim, AV Zakharov, N Southall, ... PloS one 15 (3), e0229646, 2020 | 46 | 2020 |
| Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events A Guo, R Racz, J Hur, Y Lin, Z Xiang, L Zhao, J Rinder, G Jiang, Q Zhu, ... Journal of biomedical semantics 7, 1-12, 2016 | 30 | 2016 |
| Systematic annotation and analysis of “virmugens”—Virulence factors whose mutants can be used as live attenuated vaccines R Racz, M Chung, Z Xiang, Y He Vaccine 31 (5), 797-805, 2013 | 30 | 2013 |
| Assessing the structural and pharmacological similarity of newly identified drugs of abuse to controlled substances using public health assessment via structural evaluation CR Ellis, R Racz, NL Kruhlak, MT Kim, EG Hawkins, DG Strauss, ... Clinical Pharmacology & Therapeutics 106 (1), 116-122, 2019 | 25 | 2019 |
| Target adverse event profiles for predictive safety in the postmarket setting P Schotland, R Racz, DB Jackson, TG Soldatos, R Levin, DG Strauss, ... Clinical Pharmacology & Therapeutics 109 (5), 1232-1243, 2021 | 24 | 2021 |
| DNAVaxDB: the first web-based DNA vaccine database and its data analysis R Racz, X Li, M Patel, Z Xiang, Y He BMC bioinformatics 15, 1-11, 2014 | 22 | 2014 |
| Target‐adverse event profiles to augment pharmacovigilance: a pilot study with six new molecular entities P Schotland, R Racz, D Jackson, R Levin, DG Strauss, K Burkhart CPT: Pharmacometrics & Systems Pharmacology 7 (12), 809-817, 2018 | 18 | 2018 |
| PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development JL Wilson, R Racz, T Liu, O Adeniyi, J Sun, A Ramamoorthy, ... PLoS computational biology 14 (12), e1006614, 2018 | 15 | 2018 |
| Effect of paroxetine or quetiapine combined with oxycodone vs oxycodone alone on ventilation during hypercapnia: a randomized clinical trial J Florian, R van der Schrier, V Gershuny, MC Davis, C Wang, X Han, ... Jama 328 (14), 1405-1414, 2022 | 14 | 2022 |
| Effects of sedative psychotropic drugs combined with oxycodone on respiratory depression in the rat L Xu, A Krishna, S Stewart, K Shea, R Racz, JL Weaver, DA Volpe, ... Clinical and Translational Science 14 (6), 2208-2219, 2021 | 13 | 2021 |
| VaximmutorDB: a web-based vaccine immune factor database and its application for understanding vaccine-induced immune mechanisms K Berke, P Sun, E Ong, N Sanati, A Huffman, T Brunson, F Loney, ... Frontiers in immunology 12, 639491, 2021 | 10 | 2021 |
| Oral acetylcysteine for neuropsychiatric disorders R Racz, BV Sweet, P Sohoni American Journal of Health-System Pharmacy 72 (11), 923-929, 2015 | 10 | 2015 |
| New science, drug regulation, and emergent public health issues: The work of FDA’s division of applied regulatory science K Chiu, R Racz, K Burkhart, J Florian, K Ford, M Iveth Garcia, RM Geiger, ... Frontiers in Medicine 9, 1109541, 2023 | 9 | 2023 |
| Predicting potential adverse events using safety data from marketed drugs C Daluwatte, P Schotland, DG Strauss, KK Burkhart, R Racz BMC bioinformatics 21, 1-21, 2020 | 8 | 2020 |
| Aggregation and analysis of secondary pharmacology data from investigational new drug submissions at the US Food and Drug Administration A Dodson, K Mi, DP Russo, C Scott, M Saulnier, K Snyder, R Racz Journal of Pharmacological and Toxicological Methods 111, 107098, 2021 | 5 | 2021 |
| Towards precision informatics of pharmacovigilance: OAE-CTCAE mapping and OAE-based representation and analysis of adverse events in patients treated with cancer drugs MU Wong, R Racz, E Ong, Y He AMIA Annual Symposium Proceedings 2017, 1793, 2017 | 5 | 2017 |
| Ontology-based classification and analysis of adverse events associated with the usage of chloroquine and hydroxychloroquine J Ngai, M Kalter, JB Byrd, R Racz, Y He Frontiers in Pharmacology 13, 812338, 2022 | 4 | 2022 |
| A network paradigm predicts drug synergistic effects using downstream protein–protein interactions JL Wilson, E Steinberg, R Racz, RB Altman, N Shah, K Grimes CPT: pharmacometrics & systems pharmacology 11 (11), 1527-1538, 2022 | 3 | 2022 |
